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HLA-DM Is Localized to Conventional
and Unconventional MHC Class II±Containing
Endocytic Compartments
Philippe Pierre,* Lisa K. Denzin,² binding of immunogenic peptides due to the presence
of a domain termed class II±associated Ii peptide (CLIP)Craig Hammond,² James R. Drake,³
that is thought to occupy the peptide-binding groove ofSebastian Amigorena,§ Peter Cresswell,²
class II ab dimers (Roche and Cresswell, 1991; Germain,and Ira Mellman*
1994; Ghosh et al., 1995). Once loaded with peptides,*Department of Cell Biology
the heterodimers can reach the cell surface and present²Section of Immunobiology
antigen to T cells.Howard Hughes Medical Institute
The precise sites where antigen processing, ab±Ii dis-Yale University School of Medicine
sociation, and peptide loading occur remain unclear.New Haven, Connecticut 06520-8002
Recent evidence has suggested that these events occur
in one or more specialized endocytic organelles en-
riched in MHC class II molecules (Peters et al., 1991;Summary
Amigorena et al., 1994; Tulp et al., 1994; Qiu et al., 1994;
West et al.,1994; Rudensky et al., 1994). These compart-HLA-DM molecules remove invariant (Ii) chain pep-
ments, designated MHC class II compartments (MIIC)tides from newly synthesized MHC class II complexes.
(Peters et al., 1991; Tulp et al., 1994) or class II vehiclesTheir localization may thus delineate compartments,
(CIIV) (Amigorena et al., 1994), transiently accumulatee.g., MIIC, specialized for loading peptides onto class
newly synthesized class II molecules prior to their arrivalII molecules. In murine A20 B cells, however, DM is
at the plasma membrane. In addition, they are sites ofnot restricted to specialized endosomal class II±
peptide loading, as indicated by the formation of SDScontaining vesicles (CIIV). Although DM was found in
stable ab dimers or the acquisition epitopes specific toCIIV, it was also found throughout the endocytic path-
certain antigen±MHC complexes.way, principally in lysosomes devoid of class II mole-
The relationships among MIIC, CIIV, and the conven-cules. In human lymphoblasts, HLA-DM was found in
tional endocytic organelles found in all cells remain un-structures indistinguishable from late endosomes or
clear (Mellman et al., 1995; Wolf and Ploegh, 1995). CIIVslysosomes, although in these cells the lysosomes con-
preferentially accumulate newly synthesized MHC classtained MHC class II molecules. Thus, the distribution
II and are clearly physically and biochemically distinctof HLA-DM does not necessarily identify specialized
from endosomes and lysosomes; they do, however, con-class II compartments. Many ªMIICº may represent
tain recycling receptors indicative of early endosomesconventional lysosomes that accumulate MHC class
such as transferrin receptor and surface immunoglobu-II and HLA-DM in a number of cell types.
lin, the physiological receptor for antigen in B cells (Ami-
gorena et al., 1994; J. R. D. et al., submitted). MIICs,Introduction
on the other hand, are depleted in recycling receptors
(transferrin receptor and mannose-6-phosphate recep-Major histocompatibility complex (MHC) class II mole-
tor [MPR]) and are enriched in late endocytic markerscules are heterodimeric cell surface glycoproteins that
such as lgp-A/lamp-1 and CD63 (Peters et al., 1991).bind exogenously derived antigenic peptides and pres-
These observations suggest that CIIVs may be relatedent them to CD41 T cells (for review see Germain and
to early endosomes and are distinct from or representMargoulies, 1993; Germain, 1994; Wolf and Ploegh,
a subset of MIIC, which by virtue of the presence of lgp/1995). Class II a and b chains are translocated into the
lamp markers and absence of MPR are more similar toendoplasmic reticulum where they form heterodimers
lysosomes.and associate with a third transmembrane polypeptide,
The roles of MIIC, CIIV, or other endocytic compart-the invariant chain (Ii) (Cresswell, 1992; Lamb and Cress-
ments may be clarified by determining whether thesewell, 1992). Three ab dimers and one Ii trimer assemble
structures also contain accessory proteins that play im-into nonamers (Roche et al., 1991), allowing export of
portant accessory functions in antigen processing orthe complex to the Golgi. After reaching the trans-Golgi
peptide loading. One such protein is HLA-DM (Roche,network (TGN), most of the nonamers are targeted to
1995). HLA-DM is a dimer of two membrane proteinsthe endocytic pathway due to a sorting signal in the
(DMA, DMB) related to MHC class I and II (Cho et al.,Ii cytoplasmic domain (Bakke and Dobberstein, 1990;
1991; Kelly et al., 1991). Mutant cell lines defective inPieters et al., 1993). In endocytic organelles, class II
HLA-DMA, HLA-DMB, or bothare impaired in their abilitymolecules encounter peptides generated from exoge-
to present antigens and to form SDS-stable class II abnous antigens internalized by endocytosis. The binding
dimers (Mellinset al., 1990; Riberdy and Cresswell, 1992;of peptides to class II heterodimers occurs only when
Denzin et al., 1994; Fling et al., 1994; Morris et al., 1994).Ii chain has been proteolytically cleaved and dissociated
Class II heterodimers in DM-deficient cell lines are asso-(Roche and Cresswell, 1991; Blum and Cresswell, 1988;
ciated with a nested set of peptides corresponding toNeefjes and Ploegh, 1992). Ii chain directly prevents the
the Ii chain±derived CLIP. Thus, HLA-DM is likely to
participate in the removal of CLIP from class II hetero-³Current Address: Trudeau Institute, Post Office Box 59, Saranac
dimers, an activity that can be reconstituted in vitroLake, New York 12983.
(Denzin and Cresswell, 1995; Sloan et al., 1995).§Current Address: Institut Curie, Institut National de la SanteÂ et de
la Recherche MeÂ dicale U255, 26 rue d'Ulm, 75005 Paris, France. Importantly, HLA-DM has recently been localized to
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MIIC in human lymphoblasts (Sanderson et al., 1994).
Given the uncertainty concerning the nature and origin
of class II±containing compartments in antigen-pres-
enting cells (APCs), we sought to investigate the intracel-
lular distribution of DM in greater detail. Using A20 B
cells, we have found that, as expected, DM is present
in CIIV. However, the bulk of the DM in these cells was
found in lysosomes, defined by cell fractionation and
colocalization with lysosomal membrane glycoproteins
(e.g., lgp/lamp proteins), that were devoid of MHC class
II molecules. In human PALA cells, on the other hand,
there was extensive colocalization of both class II and
HLA-DM with lgp/lamp proteins; few if any ªlysosomesº
were negative for class II or DM. These results suggest
that the distribution of HLA-DM (and MHC class II) does
not necessarily define APC-specific compartments spe-
cialized for antigenprocessing, but rather that the major-
ity of what are typically categorized as MIIC are simply Figur e 1. Expression and Assembly of Human H LA-DM in
lysosomes that have accumulated class II and DM mole- Transfected A20 Cells
cules. Murine A20 B cells were cotransfected with the cDNAs coding for
human HLA-DMA and HLA-DMB. After labeling with [35S]methionine,
cell lysates were immunoprecipitated with the anti-HLA-DMB rabbit
polyclonal antibody R.DMB-C and protein A±Sepharose. Two-Results
dimensional gel analysis was then performed with the first dimen-
sion by nonequilibrium pH gradient electrophoresis (NEPHGE) from
Expression and Assembly of HLA-DM right to left (acidic to basic) and the second dimension by SDS±
in Murine A20 Cells PAGE. Human HLA-DMB, HLA-DMA, and murine H2-MA are marked
Mouse A20 B cells are well-characterized APCs whose with arrows. The DMB protein migrated as two major species, pre-
sumably reflecting glycosylation heterogeneity (R.DMB-C does notclass II±containing compartments have been studied
detect the murine DMB homolog). Human HLA-DMA and its murinein some detail. Since the endogenous murine HLA-DM
homolog H2-MA coprecipitated with HLA-DMB, indicating that bothhomolog (H2-MA, H2-MB) was difficult to detect bio-
human and murine DMA chains were capable of pairing with the
chemically using existing reagents (see below), we pro- transfected human DMB. The identity of H2-MA and its oligomeriza-
duced stable cell lines expressing human HLA-DM. A20 tion with HLA-DMB was established by coprecipitation using cells
cells were transfected with cDNAs encoding human transfected with human DMB alone (data not shown).
HLA-DMB with or without cotransfection of HLA-DMA
(Cho et al., 1991; Kelly et al., 1991; Denzin et al., 1994).
The resulting cell lines were screened by Western blot proteins were not determined, they were not likely to
represent Ii chain or MHC class II a or b chains, sinceanalysis and immunofluorescence using a rabbit anti-
body to the cytoplasmic domain of human DMB it has previously been demonstrated that immunopre-
cipitation of HLA-DMB under identical conditions (Triton(R.DMB-C) (Denzin et al., 1994). The DM-expressing
cells were pulse-labeled with [35S]methionine for 30 min X-100 lysates) did not result in the coprecipitation of Ii
chain or MHC class II (Denzin et al., 1994). Interactionsand chased for 30 min, DM immunoprecipitated, and
coprecipitated bands analyzed by two-dimensional of HLA-DM with Ii chain have been observed in vitro
when cells are lysed with other detergents (e.g., CHAPS)nonequilibrium isoelectric focusing SDS±PAGE.
When used to analyze lysates from cells doubly (Lindstedt et al., 1995). Indeed, even associations with
class II can be observed under some conditions (unpub-transfected with both HLA-DMA and HLA-DMB cDNAs,
anti-human DMB antibody was found to precipitate not lished data).
only transfected human HLA-DMB but also two addi-
tional major proteins that, based on their molecular Intracellular Transport of Transfected HLA-DM
The coprecipitation experiments strongly suggestedweights and pIs, were likely to be the transfected human
HLA-DMA and its endogenous murine homolog H2-MA that transfected HLA-DMA dimerized with transfected
DMB and possibly with endogenous H2-MA. Neverthe-(Figure 1). Since the antibody did not react with endoge-
nous DMB, these results suggested that the transfected less, the fact that neither HLA-DMA nor H2-MA could be
directly defined made it important to determine whetherhuman DMB was capable of dimerizing with both
transfected human and endogenous mouse H2-MA. Un- transfected human DM was assembled properly in the
endoplasmic reticulum (ER) and transported through thefortunately, the lack of antibodies useful for detecting
HLA-DMA or H2-MA by immunoprecipitation or Western Golgi complex. Doubly transfected cells were [35S]methi-
onine labeled for 30 min, chased for 1, 4, and 24 hr,blot analysis (see below) made it impossible to identify
either spot definitively. The presumptive HLA-DMA spot lysed in Triton X-100, and immunoprecipitated using
anti-HLA-DMB. As shown in Figure 2 (arrowheads), awas, however, missing from cells singly transfected with
DMB cDNA, although the putative H2-MA spot remained significant fraction of the DMB became resistant to di-
gestion by endoglycosidase H (endo H) by 1 hr of chase,(data not shown).
Several minor spots were also coprecipitated with and almost completely resistant by 4 hr. Thus, much of
the transfected DMB was assembled into complexesHLA-DMB (Figure 1). Although the identities of these
HLA-DM and MHC Class II±Containing Compartments
231
Figure 2. Transport Kinetics of HLA-DM Mol-
ecules in Transfected A20 Cells
HLA-DMA/DMB- and HLA-DMB-transfected
A20 cells were labeled with [35S]methionine
for 30 min and chased with 15-fold excess
of methionine and cysteine for the indicated
period of time (0±24 hr). After immunopre-
cipitation with the anti-HLA-DMB rabbit poly-
clonal antibody R.DMB-C and protein
A±Sepharose, the precipitates were treated
with endo H or mock treated and analyzed by SDS±PAGE (10.5%). For HLA-DMA/DMB-transfected A20 cells, arrowheads indicate the position
of DMB with or without endo H treatment; the arrow indicates the position of the putative HLA-DMA. The control lanes show the background
obtained with a nonrelevant IgG. Most of the DMB molecules were resistant to endo H treatment after 1 hr of chase, indicating a normal exit
from the ER in the presence of HLA-DMA.
and exported from the ER to the Golgi complex with with both HLA-DMA and HLA-DMB cDNAs was pre-
pared by floatation in a discontinuous sucrose densitykinetics not much slower than many other membrane
gradient. As found for nontransfected cells, these mem-proteins. The fact that little or no radiolabeled DMB
branes contained z80% of the total endosomal, Golgi,was lost during the 4 hr timecourse indicates that the
lysosomal, and plasma membrane (PM) markers andtransfected protein exhibited was stable and was not
was partially depleted in the ER marker b-glucosidaseappreciably degraded in the ER. It lost z50% by 24 hr,
(Amigorena et al., 1994). The membranes were then sub-suggesting that the human DM had a long half-life after
jected to FFE. As shown in Figure 3A, the PM was foundtransit through the Golgi, in accord with its behavior
in ªunshiftedº fractions (46±58) as indicated by the mainin human lymphoblasts (Denzin et al., 1994). A protein
peak of alkaline phosphodiesterase activity and the ma-corresponding to the molecular weight of HLA-DMA co-
jority of MHC class II (detected by Western blot analysisprecipitated with DMB, but this protein remained sensi-
using a b chain±reactive polyclonal antibody: Figure 3B).tive to endo H digestion at all times of chase (Figure 2,
The lysosomal enzyme b-hexosaminidase migrated inarrow). This was similar to the behavior of endogenous
more anodally shifted fractions (56±66) characteristic ofDMA in human lymphoblasts where at least one of its
the electrophoretic mobility of conventional endosomestwo N-linked glycans remains endo H sensitive after
and lysosomes (Amigorena et al., 1994; Schmid et al.,long chase periods (Denzin et al., 1994).
1988; Marsh et al., 1987). Also, as found for non-In cells transfected with DMB alone, transport to the
transfected control A20 cells, the HLA-DMA, HLA-DMBmedial Golgi was slower and less efficient, with z80%
double transfectants exhibited a second distinct peakof the DMB remaining endo H sensitive even after 4 hr
of MHC class II that was even more anodally shiftedof chase (data not shown). Presumably, this reflects an
than the endosome±lysosome markers (Figures 3A, 3b).inability of single chains to fold and exit the ER and a
Although the CIIV peak accounted for only 5% of therelative inefficiency or lack of availability of sufficient
total MHC class II, it was selectively enriched in newlyendogenous H2-MA with which the HLA-DMB could
synthesized a/b dimers on route to the plasma mem-pair. The ER-retained form of DMB coprecipitated with
brane; A20 cells also have >90% of their total class IIseveral other polypeptides, as is often the case for mis-
on the cell surface (Amigorena et al., 1994, 1995).folded proteins.
The steady-state localization of transfected humanHaving established the proper assembly of HLA-DMB
HLA-DMB was established by Western blot analysiswith transfected DMA and its export from the ER, we
(Figure 3B). Immunoreactive DMB was found as a smallnext examined the steady-state localization of HLA-DM
but distinct peak comigrating exactly with the peak ofby cell fractionation.
MHC class II present in the anodally shifted CIIV frac-
tions. Given the recent localization of HLA-DM to MIIC
Distinct CIIV in A20 Cells Contain HLA-DM in human lymphoblasts (Sanderson et al., 1994) and
We have recently found that A20 cells contain a popula- the known role of CIIV as a site for peptide loading
tion of endocyticvesicles, enriched in newly synthesized (Amigorena et al., 1995), the presence of DM in CIIV was
MHC class II as well as a novel 50 kDa immunoglobulin expected. Far more surprising was the fact that the
a (Iga)-related membrane protein, that can be separated majority of the transfected DMB was found in FFE frac-
from endosomes and lysosomes by free flow electro- tions that did not contain much class II (especially frac-
phoresis (FFE) (Amigorena et al., 1994, 1995; J. R. D. tions 58±64). Most (z90%) of the DMB migrated as two
et al., submitted). These CIIVs exhibit a characteristic distinct peaks in the unshifted region of the FFE profile.
anodal electrophoretic mobility and comprise a vesicle The first comigrated with markers for the PM and ER,
population physically distinct from conventional endo- and the second with the lysosomal marker b-hexos-
cytic organelles that can be shown to host loading of aminidase (Figure 3). Since DMB could not be detected
peptide onto class II molecules. Thus, they may repre- by immunoelectron microscopy on the PM of trans-
sent a compartment specialized for antigen processing fected A20 cells (using streptolysin-O-permeabilized
or class II transport. Accordingly, we determined cells; unpublished data) or human lymphoblasts (on fro-
whether CIIV, like the more lysosomal MIIC found in zen sections; Sanderson et al., 1994), the first DMB peak
other APCs, contained HLA-DM. was likely to reflect DMB chains present in the ER. Al-
though all of the DMB in doubly transfected cells wasA crude membrane fraction of A20 cells transfected
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the relative lack of MHC class II in this region of the FFE
profile (Figures 3A, 3B). To determine whether the DM
in these fractions reflected its localization toendosomes
or lysosomes, the FFE endosome±lysosome fractions
pooled, avoiding inclusion of the more anodally shifted
CIIV fractions. The pooled fractions were then centri-
fuged using a 25% Percoll gradient under conditions
that allow the separation of high density lysosomes from
lower density endosomes. The membranes from the
Percoll fractions were pelleted, subjected to SDS±
PAGE, and then probed by Western blot analysis for
DMB and MHC class II. As shown in Figure 4, most
(z90%) of the HLA-DMB was found in a peak in the
heavy density region of the gradient together with the
lysosomes (indicated by b-hexosaminidase activity;
data not shown). The remainder of the DMB was recov-
ered in low density fractions, the region of the gradient
where endosomes, Golgi, and other low density mem-
branes migrate. In addition, the antibody detected a
second protein with a slightly greater mobility than au-
thentic DMB. This was judged to be a degradation prod-
uct, since it was generated by incubating crude mem-
branes for >2 hr on ice even in the presence of protease
inhibitors; appearance of the smaller band was also in-
dependent of FFE (data not shown).
Thus, the large majority of the HLA-DM that migrated
in the endosome±lysosome region of the FFE profile
was likely to reflect DM present in high density lyso-
Figure 3. Localization of HLA-DM to Specialized CIIV, Endosomes, somes rather than endosomes, although the recovery
and Lysosomes by FFE of some DM in low density fractions suggests the pres-
HLA-DMA/DMB-transfected A20 cells were fractionated by FFE and ence of at least some DM in endosomes. Since the
the distribution of MHC class II, DMB, and marker enzymes for
lysosomal fractions did not contain a correspondinglyplasma membrane (alkaline phosphodiesterase) and lysosomes
large amount of MHC class II, these data strongly sug-(b-hexosaminidase) determined. Anode is on the right; cathode on
gest that HLA-DM is not restricted to class II±containingthe left.
(A) Distribution of alkaline phosphodiesterase, b-hexosaminidase, compartments, although DM was found in CIIV. Rather,
and MHC class II. Class II distribution was determined by Western DM appears to be distributed throughout the endocytic
blot analysis using a rabbit polyclonal antibody specific for murine pathway and accumulates in conventional lysosomes,
I-Ad; reactivity of the b chain was quantified by image digitization
presumably owing to its resistance to acid hydrolases.and plotted as arbitrary units. Most of the class II was found to
While it ispossible that a specializedpopulation of MIICscomigrate with alkaline phosphodiesterase and therefore was likely
copurify with lysosomes after both FFE and Percoll gra-to representab dimers present on the cell surface. Class II molecules
were also observed in a second peak (more anodally deflected than dient centrifugation, the existence of such structures as
b-hexosaminidase) in the position of CIIV. distinct entities was also not detected by immunofluo-
(B) Distribution of human HLA-DMB (bottom) and MHC class II (top) rescence (see below).
was determined by Western blot analysis of every second FFE frac-
tion. Alignment to the indicated marker enzyme profile is shown at
the bottom. Nevertheless, while an anodally shifted peak of DMB
Localization of Transfected HLA-DMB andwas always found as comigrating with the anodally shifted CIIV
Endogenous H2-MB to Lysosomespeak, the two major peaks of DMB were in fractions (48±52) con-
taining markers for PM, ER (glucose-6-phosphatase; data not by Fluorescence Microscopy
shown), and endosomes and lysosomes (56±64). To ensure that the lysosomal distribution of HLA-DM in
A20 cells was not due to overexpression of a transfected
cDNA, we confirmed the localization of human and en-eventually transported to the Golgi, the presence of
some DMB in the ER at equilibrium is consistent with dogenous DM by immunofluorescence. First, transfected
A20 cells were stained for human DMB, MHC class II,its slightly slowed rate of acquisition of endo H resis-
tance (see above). The second peak of HLA-DM showed and the late endosome±lysosome membrane protein
lgp-B (lgp-110/lamp-2; Kornfeld and Mellman, 1989).that a large pool of the protein was present in structures
with an electrophoretic mobility identical to endosomes The cells were examined by confocal microscopy, and
the relative localization of both markers determined byand lysosomes.
merging the two images. As shown in Figure 5 (upper
left), human DMB (green) was found to colocalize exten-HLA-DM Accumulates in Conventional
Lysosomes and, to a Lesser sively with lgp-B/lamp-2 (red), thus yielding a yellow
fluorescence signal due to the coincidence of the TexasExtent, Endosomes
The large amount of HLA-DM in the endosome± red and fluorescein isothiocyanate fluorescence. Few
lgp-B/lamp-2-positive structures were seen that werelysosome fractions was more difficult to explain given
HLA-DM and MHC Class II±Containing Compartments
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Figure 4. HLA-DMB Is Associated with High
Density Lysosome-Like Membranes after
Percoll Gradient Centrifugation
The endosome±lysosome peak obtained by
FFE (e.g., Figure 3A, fractions 59±61) was
pooled and further fractionated by centrifu-
gation in 25% Percoll density gradients under
conditions that separate heavy density lyso-
somes from lower density endosomes. Mem-
branes were collected from individual frac-
tions and analyzed by Western blot using
antibodies to human HLA-DMB (top) or MHC class II (b chain, bottom). Most (>80%) of the HLA-DMB was found near the bottom of the
gradient cosedimenting with the b-hexosaminidase activity (data not shown). The remainder of the DMB was recovered at the top of the
gradient, in a region containing endosomes. The class II molecules (bottom) were detected only at the top of the gradient and were thus
resolved from the bulk of the HLA-DM. Accordingly, most of HLA-DM in A20 cells was found in class II±negative lysosomes.
negative for DM, while occasionally, DM-positive and virtually all cell types studied thus far (Kornfeld and Mell-
man, 1989), these results suggest that most or all latelgp-B/lamp-2-negative structures were seen. Since lgp/
lamp is found in all late endosomes and lysosomes in endosomes and lysosomes contain HLA-DM.
Figure 5. Localization of HLA-DM and Class II Molecules in Transfected A20 and PALA Cells by Immunofluorescence Confocal Microscopy
A20 cells doubly transfected with human HLA-DMA and HLA-DMB were stained with antibodies to human DMB (green) and the lysosomal
membrane protein lgp-B (red) (upper left) or MHC class II (green) and lgp-B (red) (upper right). Optically merged images are shown such that
coincident staining appears yellow. Although extensive colocalization between DMB and lgp-B was observed (yellow), little colocalization
was evident between class II and lgp-B-positive structures. Most of the class II staining was limited to the cell surface, which generated a
characteristic rim pattern. Occasionally, owing to the presence of plasma membrane contained within a given optical section, diffuse areas
of class II also appeared to be intracellular. When class II±positive vesicles were clearly visible, however, they were rarely coincident with
lgp-B staining pattern (arrow). PALA cells were stained with the rabbit polyclonal to HLA-DMB (green) and a mouse monoclonal antibody to
the lysosomal membrane marker CD63 (red) (lower left). A high degree of colocalization between the two markers was observed (yellow),
indicating that most of the HLA-DM in these cells is found in lysosomal structures. In the lower right, PALA cells were stained using a mouse
monoclonal antibody against class II (DR3, green) and a rabbit polyclonal antibody to the lysosomal membrane protein lgp-A (red). Although
most of the class II was found on the cell surface, intracellular class II±positive vesicles were clearly positive for lgp-A (yellow color; arrow).
The optical section (0.5 mm) was chosen particularly thin here, to avoid any surface class II signal diffusion over the lysosomes which tend
to accumulate at the periphery of the cell. In control experiments, CD63 and lgp-A were shown to give indistinguishable staining patterns;
different antibodies were used here to permit use of the available polyclonal and monoclonal antibodies to HLA-DM and DR3, respectively.
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Figure 6. Lysosomal Localization of Endoge-
nous H2-M in Normal A20 Cells by Immuno-
fluorescence Confocal Microscopy
Nontransfected A20 cells were stained using
antibodies to endogenous murine H2-MB
(red) and lgp-B (green). Optically merged im-
ages are shown such that coincident staining
appears yellow. It is evident that most of the
H2-MB in these cells colocalizes with the ly-
sosomal marker lgp-B.
Conversely, class II molecules (green) were found be present in at least some structures, suggesting that
a portion of the H2-MB is present in early endocyticmainly on the plasma membrane, with little intracellular
class II detectable in lgp-B/lamp-2-positive compart- compartments (as suggested by the cell fractionation
results). Unfortunately, theanti-H2-MB antibody was notments (Figure5, upper right). In some cells, the extensive
plasma membrane staining appeared to generate large suitable for Western blot analysis.
regions of intracellular class II staining due to the occur-
rence of plasma membrane within a given optical sec- HLA-DM and MHC Class II Colocalize
in Lysosomes in Humantion. When individual class II±positive vesicles (green)
were visible intracellularly, however, they were rarely PALA Lymphoblasts
It is clear that many human lymphoblastoid cell linescoincident (yellow) with lgp-B staining (red) (and vice
versa). This was in accord with our and previously pub- exhibit considerable colocalization of MHC class II with
HLA-DM and lgp/lamp-positive structures termed MIIClished cell fractionation experiments (Amigorena et al.,
1994; Barnes and Mitchell, 1995) that show A20 cells to (Peters et al., 1991; Sanderson et al., 1994). MIICs have
been extensively characterized by immunoelectron mi-localize little class II in lysosomes. Thus, DM-positive
late endosomes and lysosomes in A20 cells were gener- croscopy, an approach that has yielded much informa-
tion concerning their morphology and composition, butally negative for class II, suggesting further that, despite
their efficiency at antigen processing, A20 cells are de- has not established whether MIICs exist as a population
distinct from other conventional endocytic organelles.pleted in lgp/lamp-rich MIIC.
Using a polyclonal rabbit antibody to murine H2-MB Accordingly, we used confocal microscopy to charac-
terize the relative distributions of HLA-DM, class II, and(gift from V. Lotteau and P. A. Peterson, San Diego,
California), we next established that endogenous mouse lgp/lamps in PALA cells, a human lymphoblast cell line
known to contain abundant MIICs. As found in A20 cells,DMB was also largely contained within lgp-B-positive
vesicles, even in nontransfected A20 cells. In themerged HLA-DMB (green) colocalized extensively with the lyso-
somal marker CD63 (red) (see Figure 5, lower left). Fewfluorescent image shown in Figure 6, most of endoge-
nous H2-MB colocalized with lgp-B in lysosomes. Al- DM-negative and CD63-positive structures were found,
although occasional DM-positive CD63-negative vesi-though the immunofluorescence signal was not as
strong as for transfected DM, these results strongly sug- cles could be observed. CD63 itself colocalized com-
pletely with antibody to human lamp-1 (data not shown).gest that the presence of the human DMB in lgp/lamp-
positive class II±negative compartments was not the Unlike A20 cells, however, much of the intracellular
MHC class II in PALA cells (HLA-DR3, green) was alsoresult of HLA-DM transfection. The same experiment
was performed using antibody to transferrin receptor found in the CD63/lgp-positive (red) structures (see Fig-
ure 5, lower right). Owing to the preponderance of sur-instead of lgp-B (data not shown), in which case rela-
tively little colocalization with endogenous H2-MB could face class II in these cells, very thin optical sections
were required to visualize intracellular structures.be observed, although the two markers did appear to
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Although this greatly reduced the number of internal
vesicles visible in any one cell profile, almost all CD63-
positive structures were also positive for class II (indi-
cated by the yellow staining and absence of red staining
vesicles). This result was consistent among different
experiments and different optical sections. Thus, much
of the MHC class II in PALA cells was present in late
endosomes or lysosomes, in contrast with A20 B cells.
The fact that few CD63-positive structures were ob-
served that were clearly negative for MHC class II sug-
gested that HLA-DM and class II±containing MIIC, as is
usually implied, do not exist as a compartment distinct
from the population of conventional lysosomes in these
cells.
The colocalization of HLA-DM and class II heavy den-
sity lysosomes in PALA cells was further indicated by
Percoll gradient centrifugation of crude homogenates,
as opposed to FFE fractions (as discussed above in
Figure 4). As shown in Figures 7A and 7B, the bulk of
the b-hexosaminidase activity was found at the bottom
of the gradients (peaks 3±7) in postnuclear supernatants
of both PALA and A20 cells. However, in agreement with
the confocal microscopy, only in PALA cells (Figure 7A)
was a distinct peak of MHC class II observed in the
heavy density lysosomal fractions. The major peak of
low density class II in both cells reflects the presence
of class II on the plasma membrane and, to a far lesser
extent, in low density CIIV and endosomes. Thus, in
agreement with the confocal microscopy, PALA cells
but not A20 cells localize significant amounts of MHC
class II in lgp/lamp-positive structures indistinguishable
from lysosomes. Nevertheless, both cell types mediate
the efficient lysosomal localization of HLA-DM.
Discussion
Our results suggest, contrary to initial impressions, that
Figure 7. Class II Molecules Are Associated with High Density Lyso-HLA-DM is not necessarily a marker of specialized MHC
some-Like Membranes in PALA Cells but Not in A20 Cells after
class II±containing compartments but can be found Percoll Gradient Centrifugation
in conventional endocytic organelles irrespective of Postnuclear supernatants of PALA and A20 cells were fractionated
whether they contain class II. This was most clearly by centrifugation in 25% Percoll density gradients under conditions
illustrated in A20 B cells, where the bulk of the HLA-DM that separate heavy density lysosomes from lower density endo-
somes. Membranes were collected from individual fractions andwas found in heavy density class II±negative vesicles
analyzed by Western blot using antibodies to human DR3 (b chain)that were indistinguishable from lysosomes of the type
or mouse I-Ad class II molecules (b chain), the reactivity of the bcommon to these and all other cells. A similar situation
chains were quantified by image digitization and plotted as arbitrarywas observed for PALA cells despite the fact that much
units. In both cases, the bulk of the b-hexosaminidase activity was
of the intracellular class II in these cells colocalized found at the bottom of the gradient (peaking in fraction 3±5), indica-
together with HLA-DM in structures (MIIC) that were tive of the sedimentation of the denser lysosomes. Most of the class
II molecules are found in the lower density area corresponding tomore likely to be lysosomes than specialized antigen-
the plasma membrane.processing organelles.
(A) In PALA cells, a clear accumulation of class II molecules is foundA20 cells do, however, contain a population of CIIVs
at the bottom of the gradient cosedimenting with lysosomes.that are physically and biochemically distinct from con-
(B) Conversely, in A20 cells, very little class II molecules are found
ventional endosomes and lysosomes. By these impor- cosedimenting with lysosomes and clearly not as a distinct peak.
tant criteria, CIIVs comprise a specialized or at least an
unconventional endosome population. These vesicles
were found to contain HLA-DM by FFE, a cell-fraction- structures found in the FFE CIIV fractions are positive
for MHC class II (P.Webster and I. M., unpublished data).ation strategy that appears to separate CIIV from all
other known intracellular organelles. The comigration of Since CIIVs can host the final steps in the dissociation of
Ii chain from newly synthesized class II (Amigorena etDM together with the anodally shifted peak of MHC class
II is thus strong evidence for DM being contained within al., 1995), the observation that they contain HLA-DM
supports the possibility that CIIVs play a role in peptideCIIV as opposed to some membranes contaminating
the CIIV fraction. Virtually all of the membrane-bound loading in intact cells. The relative lack of high density
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lysosome-like MIIC in A20 cells further increases the low density membranes that may correspond to CIIVs
(unpublished data).likelihood that antigen processing must occur in CIIV or
other low density structures. Indeed, a variety of anti- Third, when HLA-DM (or Ii chain) is transfected into
nonprofessional APCs such as Cos cells, it equilibratesgens have been found to be converted into immuno-
genic complexes in A20 cells without reaching late or into the entire pool of presumably preeÈ xisting lgp/lamp-
positive late endosomes and lysosomes, rather thanheavy density endocytic compartments (Barnes and
Mitchell, 1995). Whether this occurs in CIIV, or perhaps defining a distinct vesicle population (Marks et al., 1995;
Lindstedt et al., 1995).in low density (early) endosomes that we expect also
might contain small amounts of class II and HLA-DM Fourth, although MIICs are typically identified as hav-
ing internal multivesicular or multilaminar structures,remains to be determined. Conversely, the delivery of
antigen to lysosomes in A20 cells does not ensure its these morphological entities are also typical of lyso-
somes in cells that do not even express MHC class IIpresentation when internalized on antigen receptor
bearing recently identified mutations in the membrane such as neurons (Holtzman, 1989). Often, lysosomes
with pronounced intramembranous arrays accumulateanchoring domain (Mitchell et al., 1995). Thus, reaching
lysosomes is neither necessary nor sufficient for antigen following autophagy (Dunn, 1994; Marzella and Glau-
mann, 1987) or when cells encounter large quantitiespresentation in these cells.
In many of the lymphoid and macrophage cell types of poorly digestible membrane or soluble components.
This may in part account for the apparent induction ofstudied thus far, significant amounts of MHC class II are
localized to heavy density lgp/lamp-positive structures multilaminar MIICs observed upon overexpression of
hydrolase-resistant MHC class II in epithelial cells (Cala-that also contain HLA-DM. By convention, these struc-
tures are collectively termed MIICs (Peters et al., 1991), fat et al., 1994).
Regardless of whether specialized compartments ex-but in fact may represent a structurally heterogeneous
array of different organelles or organelle subpopula- ist for antigen processing, our results do suggest that
the intracellular transport of class II and HLA-DM aretions. Some MIICs may represent APC-specific special-
izations of the endocytic pathway, or specializations differentially regulated. It seems likely that cytoplasmic
domain sorting signals found in the Ii chain of the classinduced by the expression of MHC class II in nonprofes-
sional APCs (Romagnoli et al., 1993; Calafat et al., 1994). II complex (Bakke and Dobberstein, 1990; Pieters et al.,
1993) as well as on the DMB cytoplasmic domain (MarksHowever, it is possible that most or all MIIC represent
conventional late endosomes or lysosomes that have et al., 1990; Lindstedt et al., 1995) specify transport
of newly synthesized molecules to endosomes, oftenaccumulated MHC class II and HLA-DM simply by virtue
of the expression of these proteins and their relative directly from the TGN (Wolf and Ploegh, 1995; Mellman
et al., 1995). However, as mentioned above, the fact thatresistance to proteolysis by lysosomal hydrolases. Sev-
eral considerations favor this possibility. different cell types localize different fractions of DM
versus class II in lysosomes demonstrates that afterFirst, as we have shown here, HLA-DM in A20 cells
is sorted from MHC class II such that DM accumulates leaving the TGN, DM and class II can be sorted from
each other. Haplotype differences alone cannot accountin late endocytic structures, while class II molecules
do not. These late endocytic structures have all the for the differential intracellular distributions of class II
molecules we have observed. A20 cells endogenouslycharacteristics of lysosomes and, indeed, overlap en-
tirely with the population lgp/lamp-positive structures express I-Ad, but when transfected with I-Ab, class II
molecules still fail to accumulate in lysosomes. Interest-that define lysosomes in all cells. By definition, the lyso-
some-like class II±negative structures that accumulate ingly, this distribution can be altered upon treatment of
cells with the protease inhibitor leupeptin, in which caseHLA-DM in A20 cells cannot be MIICs. Similarly, in PALA
cells, confocal microscopy failed to identify a population I-Ab molecules, but not I-Ad molecules, can be induced
to reach lysosomes (S. A. et al., unpublished data). Thisof class II±negative lgp/lamp-positive lysosomes that
were distinct from class II±positive lgp/lamp-positive result might create an interesting link with the observa-
tion that some haplotypes (I-Ak) are strongly dependentªMIICs.º Thus, either all the lysosomes in these cells
had been converted to specialized MIICs or the bulk of on HLA-DM for peptide loading and some are not (I-Ad)
(Stebbins et al., 1995). Indeed, there is evidence thatMIICs represent lysosomes that have accumulated MHC
class II. Although confocal microscopy is of lower reso- transport of class II molecules to the surface can be
influenced by the dissociation of Ii chain or peptidelution than electron microscopy, it has the decided ad-
vantage of allowing a better evaluation of total organelle loading (Amigorena et al., 1995; Germain and Rinker,
1993; Romagnoli et al., 1993) and possibly by sequencespopulations.
Second, membranes positive for both MHC class II on the b chain extracellular domain or cytoplasmic tail
(Chervonsky et al., 1994; Griffith et al., 1988; Smiley etand lysosomal markers have never been clearly defined
as a population physically distinct from the bulk of lyso- al., 1996).
Lysosomes are generally considered as an intracellu-somes in any cell type. Thus far, only those class II±
containing endocytic vesicles that are relatively de- lar dead end from which escape back to the plasma
membrane, if it occurs at all, is inefficient (Kornfeld andpleted in lgp/lamp proteins have been resolved from
lysosomes, either by electrophoresis or density gradient Mellman, 1989). Thus, lysosomes would appear to be a
kinetically inefficient site from which to recruit immuno-centrifugation (Amigorena et al., 1994; Tulp et al., 1994;
Castellino and Germain, 1995). Interestingly, the bulk of genic MHC class II complexes. However, it is clear that
some membrane proteins can recycle to the surfaceintracellular class II in populations of bone marrow±
derived dendritic cells is also found in nonlysosomal from lysosomes, albeit slowly. This may explain why
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a modified Bio-Rad MRC650 microscope using 0.5±0.75 mm opticalsome cell types require many hours to complete the
sections.transport of newly synthesized class II molecules to the
cell surface (Neefjes et al., 1990; Peters et al., 1991; Tulp
Immunoprecipitation, Pulse±Chase Experiments,
et al., 1994). In A20 cells, where the transport of newly and Two-Dimensional Gel Analysis
synthesized ab dimers may be delayed only by passage DM-expressing cells (1 3 106) were pulse-labeled with 1 mCi of
through CIIV, appearance on the plasma membrane is [35S]methionine trans label (ICN biochemical, Cosa Mesa, California)
in labeling medium for 30 min and chased for various times at 378Cdelayed by only 1±2 hr (Amigorena et al., 1994).
in IDMEM, 10% FCS with a 15-fold excess of cold methionine andWhy is it important to determine whether, or the extent
cysteine as described previously. Radiolabeled cell pellets wereto which, specialized class II compartments exist as
extracted for 30 min on ice in 10 mM Tris±HCl, 150 mM NaCl (pH 7.4)
opposed to conventional endosomes and lysosomes? containing 1% Triton X-100 (Sigma), 0.5 mM PMSF, and protease
The major reason is that it is of fundamental importance inhibitor cocktails as described (Denzin et al., 1994). After the nuclear
to understanding the degree towhich professional APCs material was removed by centrifugation, lysates were precleared
overnight with normal rabbit serum and protein A±Sepharose (Phar-are differentiated from other cells to facilitate their anti-
macia, Piscataway, New Jersey) at 48C.Cell lysateswere then immu-gen-processing functions. It is also critical to our under-
noprecipitated with the anti-HLA-DMB rabbit polyclonal antibodystandingof the targeting signals that specify the intracel-
R.DMB-C and protein A±Sepharose. Sepharose pellets were
lular transport of MHC class II, Ii chain, and HLA-DM. If washed three times with extraction buffer. For endo H (Boehringer
specialized compartments exist, then specific sorting Mannheim, Indianapolis, Indiana) digestion, pellets were treated as
signals specifying component transport to them must already described (Denzin et al., 1994) or directly boiled in sample
buffer for two-dimensional analysis. The immunoprecipited materialalso exist; if not, more general signals for endosomal
was analyzed either on one dimension gel by 10.5% SDS±PAGE ortargeting or retention would suffice. Thus, understand-
for two-dimensional analysis, in the first dimension by nonequilib-ing the cell biological basis of antigen processing will
rium pH gradient electrophoresis (NEPHGE) and in the second di-
require the development of precise criteria to evaluate mension by 10.5% SDS±PAGE as described (Denzin et al., 1994).
the features of class II±containing compartments.
Cell Fractionation by FFE
Experimental Procedures HLA-DMA/DMB-transfected A20 cells were grown in a-MEM, 10%
FCS, 50 mM b-mercaptoethanol, and 500 mg/ml hygromycin B. We
harvested 500 ml at 0.8 3 106 cells/ml and homogenized them asCell Lines
previously described (Amigorena et al., 1994). Postnuclear superna-HLA-DMA/DMB-transfected murine A20 B cells were grown in
tants were fractionated by floatation (90 min at 35,000 rpm in aa-MEM, 10% fetal calf serum (FCS), 50 mM b-mercaptoethanol and
Beckman SW 41-Ti rotor) in a discontinuous sucrose density gradi-500 mg/ml hygromycin B in the presence of 5% CO2 at 378C. The
ent (1.4, 1.25, 0.25 M sucrose in TEA buffer). Lowdensity membraneshuman Epstein±Barr virus±transformed B cell line PALA (DR3.Dw17)
enriched in endosomes (1.25±0.25 M interface) were collected, ad-was maintained in Iscove's DMEM (IDMEM) with 10% FCS in the
justed to 0.24 M sucrose, and briefly trypsinized (3 ng of trypsin/mgpresence of 5% CO2 at 378C.
of protein at 378C for 10 min). The reaction was stopped with an
excess of soybean trypsin inhibitor. The sample was applied to aGeneration of Stable Transfectant Cell Lines
Dr. Weber GmbH Octopus free flow electrophoresis chamber at aHLA-DMA/DMB were amplified from a Raji cDNA library using poly-
rate of 100 ml/min with a flow of 250 ml/hrat 110 mA. Markerenzymesmerase chain reaction as previously described (Denzin et al., 1994).
and protein assay have been described elsewhere (Amigorena etMurine A20 B cells were transfected with the eucaryotic expression
al., 1994; Schmid et al., 1988). MHC class II and HLA-DMB distribu-vector pMCFRhyg (1 mg) carrying the cDNAs coding for human HLA-
tion have been determined by Western blot analysis of membranesDMB and an hygromycin resistance gene. pMCFR (20 mg) carrying
collected by centrifugation (30 min at 14,000 rpm in a refrigeratedthe cDNA coding for HLA-DMA was used when it was cotransfected
microfuge) using rabbit polyclonal antibodies against I-Ad (gift fromwith DMB. Electroporation was performed with a Bio-Rad gene
R. Kubo) and R.DMB-C followed by enhanced chemiluminescencepulser (Richmond, California) at 270 V and 500 mF. The pMCFR
detection (Amersham, Arlington Heights, Illinois). Reactivity of theexpression vector was a gift from T. Novak (Yale University) and
b chains was quantified by image digitization using a Visage 2000provides a high level of expression in lymphocytes. pMCFR contains
densitometer (Bioimage, Ann Harbor, Michigan).a T cell±specific transcriptional enhancer comprised of the long
terminal repeat from a mink cell focus-forming murine leukemia virus
(MCF-13) and a translational enhancer from the R-U5 region of the Percoll Gradient Centrifugation
Transfected A20 cells were fractionated by FFE; fractions (59±61)human T leukemia virus 1 (Denzin et al., 1994). The cells were se-
lected in IDMEM with 500 mg/ml of hygromycin and cloned by lim- containing the b-hexosaminidase peak activity were pooled and
mixed with Percoll (Sigma) up to 25%. A 10 ml sample was loaded oniting dilution in 96-well plates as described (Denzin et al., 1994).
a 60% optiprep (Nycomed, Oslo, Norway) cushion and centrifuged in
a Beckman Ti50 rotor at 18000 rpm for 90 min at 48C. Fractions (500Antibodies and Immunofluorescence
ml) were collected, diluted in TEA±sucrose, and the membranesCells were fixed in 3.5% paraformaldehyde (in phosphate-buffered
collected by centrifugation. Pelleted membranes were analyzed bysaline) and permeabilized in a-MEM containing 10% FCS, 10 mM
SDS±PAGE and Western blot, followed by enhanced chemilumines-HEPES (pH 7.4) and 0.05% saponin. Human HLA-DMB was visual-
cence detection (Amersham). Postnuclear supernatants were pre-ized using the R.DMB-C antibody (Denzin et al., 1994); murine H2-
pared from A20 and PALA cells as previously described (AmigorenaMB was visualized using the K553 rabbit polyclonal antibody ob-
et al., 1994). Postnuclear supernatant (1 ml) was mixed with 9 ml oftained from V. Lotteau and P. A. Peterson (San Diego, California);
TEA 250 and Percoll up to 25% before being centrifuged and ana-murine I-Ad was visualized using a rabbit polyclonal antibody (ob-
lyzed as described above.tained from R. Kubo); murine lgp-B was visualized using the rat anti-
mouse lgp-B monoclonal antibody GL2A7 (Granger et al., 1990);
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